Figure 2.
Representative X-rays and micro CT reconstructions of the implant at 6 months indicated that without growth factor inclusion, the defects failed to bridge (A); and (B). An increased incidence of bridging was observed in groups administered with VEGF, PDGF and BMP-2 (C;D), as well as groups administered with BMP-2 alone (E;F).